IRAK4 and systemic lupus erythematosus: Additionally, mouse models of TLR7-driven lupus are dependent on IRAK4 (112), and several IRAK4 inhibitors are currently in phase I/II clinical trials (113), thus treatment with IRAK4 inhibitors may also be successful.